Marinus Pharmaceuticals reported $-30099000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
ALKERMES ALKS:US USD -60641000 26.18M
Amgen AMGN:US USD 2.66B 71M
Aptinyx Inc APTX:US USD -14657000 2.45M
Biogen BIIB:US USD 872.1M 68.8M
Eisai 4523:JP JPY -2181000000 9.62B
Enanta Pharmaceuticals ENTA:US USD -27048000 5.49M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
Gilead Sciences GILD:US USD 2.81B 784M
Intercept Pharmaceuticals ICPT:US USD -10144000 3.22M
Intra Cellular Therapies ITCI:US USD -55629000 32.29M
Marinus Pharmaceuticals MRNS:US USD -30099000 6.67M
Minerva Neurosciences NERV:US USD -5207150 1.76M
Neurocrine Biosciences NBIX:US USD 87.8M 33.1M
Ptc Therapeutics PTCT:US USD -68187000 24.17M
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M
Sarepta Therapeutics SRPT:US USD -131355000 79.78M
Vertex Pharmaceuticals VRTX:US USD 1.13B 7.4M
YTE INCY:US USD 118.25M 142.04M